Company Data
Puma Biotechnology Inc
Ticker
PBYI
Current Price
$6.21 -3.27%
Market Cap
$315.9M
Price Target
Refer to Report
Volume
654.8K
52wk Range
$2.575 - $7.68
Overview
Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357.